Recognized for Practical AI Implementation and Strategic Business Applications
Jason Hwang, Executive Director of Strategic Planning at REV-MED, has been awarded the Innovation Leadership Award at the inaugural AI Convergence Advanced CEO Program (AICAP) hosted by the Korea Productivity Center.
Launched in 2025, AICAP is an executive education program designed for CEOs and senior leaders seeking to integrate artificial intelligence into business management and organizational strategy. Throughout the program, Jason Hwang focused not only on understanding AI technologies but also on exploring practical methods for applying AI to real-world corporate strategy and decision-making.
The award was presented in recognition of his case study presentation, which highlighted actual business challenges encountered at REV-MED and demonstrated how AI-driven approaches could be incorporated into strategic planning and operational improvement initiatives.
According to attendees, the presentation stood out for its practical relevance and real-world insights. Rather than focusing solely on theoretical concepts, Hwang shared firsthand experiences from the business environment and discussed actionable approaches to leveraging AI within corporate operations. The presentation received strong positive feedback from fellow participants and faculty members.
Jason Hwang commented:
“This award is not only a personal achievement but also recognition of REV-MED’s commitment to innovation. We will continue to strategically leverage AI technologies to create differentiated value for our customers and strengthen our competitive capabilities.”
As a global regenerative medicine company, REV-MED continues to develop and supply advanced biologics processing and cell concentration technologies, including solutions for autologous blood- and cell-based applications. The company remains focused on combining technological innovation with strategic business development to support the advancement of healthcare solutions worldwide.
Source: BioTimes
Recognized for Practical AI Implementation and Strategic Business Applications
Jason Hwang, Executive Director of Strategic Planning at REV-MED, has been awarded the Innovation Leadership Award at the inaugural AI Convergence Advanced CEO Program (AICAP) hosted by the Korea Productivity Center.
Launched in 2025, AICAP is an executive education program designed for CEOs and senior leaders seeking to integrate artificial intelligence into business management and organizational strategy. Throughout the program, Jason Hwang focused not only on understanding AI technologies but also on exploring practical methods for applying AI to real-world corporate strategy and decision-making.
The award was presented in recognition of his case study presentation, which highlighted actual business challenges encountered at REV-MED and demonstrated how AI-driven approaches could be incorporated into strategic planning and operational improvement initiatives.
According to attendees, the presentation stood out for its practical relevance and real-world insights. Rather than focusing solely on theoretical concepts, Hwang shared firsthand experiences from the business environment and discussed actionable approaches to leveraging AI within corporate operations. The presentation received strong positive feedback from fellow participants and faculty members.
Jason Hwang commented:
“This award is not only a personal achievement but also recognition of REV-MED’s commitment to innovation. We will continue to strategically leverage AI technologies to create differentiated value for our customers and strengthen our competitive capabilities.”
As a global regenerative medicine company, REV-MED continues to develop and supply advanced biologics processing and cell concentration technologies, including solutions for autologous blood- and cell-based applications. The company remains focused on combining technological innovation with strategic business development to support the advancement of healthcare solutions worldwide.
Source: BioTimes